SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2025 and provided full year 2025 guidance. Second Quarter 2025 Highlights Achieved record second quarter sales both in the United States (U.S.) and internationally. Demonstrated year-over-year and sequential gross margin improvement. Initiated an early access program for the t:slim X2™ insulin pump w
Related Questions
What is the scope and timeline of the early access program for the t:slim X2™ pump, and what revenue impact is expected?
What were the operating expenses, R&D spending, and SG&A trends for the quarter?
What was the percentage growth in U.S. and international sales versus the prior quarter and year‑over‑year?
What is the updated full‑year 2025 revenue and EPS guidance, and how does it compare to previous guidance and analyst expectations?
What were the net income or loss figures for the quarter, and what was the impact on earnings per share (EPS)?
How does the company’s cash balance, cash flow from operations, and any debt changes look after Q2?
How does Tandem’s growth rate and market share compare with other major insulin pump manufacturers (e.g., Medtronic, Insulet) for the same period?
What are the analyst reactions and target price revisions in response to these results?
Is there any indication of changes in pricing, reimbursement, or insurance coverage that could impact future revenue?
What are the potential regulatory or reimbursement risks that could affect the guidance?
How did the reported Q2 2025 revenue compare to consensus estimates?
What guidance does the company give for future product launch timelines and pipeline developments?
What were the actual gross margin numbers and how did they improve sequentially and year‑over‑year?
How many units of the t:slim X2™ insulin pump were sold in Q2, and how does that compare with prior periods?
What technical or supply chain challenges were mentioned and how might they affect future production?